Your browser doesn't support javascript.
loading
Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet, Natalie; DeScipio, Cheryl; Murphy, Kathleen M; Beierl, Katie; Adams, Emily; Vang, Russell; Ronnett, Brigitte M.
Afiliação
  • Banet N; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • DeScipio C; 1] Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA [2] Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Murphy KM; ProPath, Dallas, TX, USA.
  • Beierl K; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Adams E; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Vang R; 1] Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA [2] Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Ronnett BM; 1] Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA [2] Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Mod Pathol ; 27(2): 238-54, 2014 Feb.
Article em En | MEDLINE | ID: mdl-23887308
ABSTRACT
Immunohistochemical analysis of cyclin-dependent kinase inhibitor 1C (CDKN1C, p57, Kip2) expression and molecular genotyping accurately classify hydatidiform moles into complete and partial types and distinguish these from non-molar specimens. Characteristics of a prospective series of all potentially molar specimens encountered in a large gynecologic pathology practice are summarized. Initially, all specimens were subjected to both analyses; this was later modified to triage cases for genotyping based on p57

results:

p57-negative cases diagnosed as complete hydatidiform moles without genotyping; all p57-positive cases genotyped. Of the 678 cases, 645 were definitively classified as complete hydatidiform mole (201), partial hydatidiform mole (158), non-molar (272), and androgenetic/biparental mosaic (14); 33 were unsatisfactory, complex, or problematic. Of the 201 complete hydatidiform moles, 104 were p57-negative androgenetic and an additional 95 were p57-negative (no genotyping), 1 was p57-positive (retained maternal chromosome 11) androgenetic, and 1 was p57-non-reactive androgenetic; 90 (85%) of the 106 genotyped complete hydatidiform moles were monospermic and 16 were dispermic. Of the 158 partial hydatidiform moles, 155 were diandric triploid, with 154 p57-positive, 1 p57-negative (loss of maternal chromosome 11), and 1 p57-non-reactive; 3 were triandric tetraploid, with 2 p57-positive and 1 p57-negative (loss of maternal chromosome 11). Of 155 diandric triploid partial hydatidiform moles, 153 (99%) were dispermic and 2 were monospermic. Of the 272 non-molar specimens, 259 were p57-positive biparental diploid, 5 were p57-positive digynic triploid, 2 were p57-negative biparental diploid (no morphological features of biparental hydatidiform mole), and 6 were p57-non-reactive biparental diploid. Of the 14 androgenetic/biparental mosaics with discordant p57 expression, 6 were uniformly mosaic and 8 had a p57-negative androgenetic molar component. p57 expression is highly correlated with genotyping, serves as a reliable marker for diagnosis of complete hydatidiform moles, and identifies androgenetic cell lines in mosaic conceptions. Cases with aberrant and discordant p57 expression can be correctly classified by genotyping.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Mola Hidatiforme / Biomarcadores Tumorais / Inibidor de Quinase Dependente de Ciclina p57 Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Mola Hidatiforme / Biomarcadores Tumorais / Inibidor de Quinase Dependente de Ciclina p57 Idioma: En Ano de publicação: 2014 Tipo de documento: Article